Azithromycin to Reduce Mortality — An Adaptive Cluster-Randomized Trial,The New England Journal of Medicine

当前位置： X-MOL 学术 › N. Engl. J. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Azithromycin to Reduce Mortality — An Adaptive Cluster-Randomized Trial
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-08-22 , DOI: 10.1056/nejmoa2312093
Kieran S O'Brien ₁ , Ahmed M Arzika ₁ , Abdou Amza ₁ , Ramatou Maliki ₁ , Bawa Aichatou ₁ , Ismael Mamane Bello ₁ , Diallo Beidi ₁ , Nasser Galo ₁ , Naser Harouna ₁ , Alio M Karamba ₁ , Sani Mahamadou ₁ , Moustapha Abarchi ₁ , Almou Ibrahim ₁ , Elodie Lebas ₁ , Brittany Peterson ₁ , Zijun Liu ₁ , Victoria Le ₁ , Emily Colby ₁ , Thuy Doan ₁ , Jeremy D Keenan ₁ , Catherine E Oldenburg ₁ , Travis C Porco ₁ , Benjamin F Arnold ₁ , Thomas M Lietman ₁ ,

Affiliation

Twice-yearly mass distribution of azithromycin to children is a promising intervention to reduce childhood mortality in sub-Saharan Africa. The World Health Organization recommended restricting dis...

中文翻译：